Schrödinger provides a computational platform for drug discovery used by biopharma, academia, and government labs worldwide. It offers an integrated software suite for molecular modeling and simulations that clients license or access through collaborative research, often complemented by joint drug-discovery programs. The company differentiates itself with a long history (since 1990), a global footprint in 70+ countries, and a combination of software tools plus collaborative services. Its goal is to advance science and talent by strengthening its platform while helping partners discover and develop medicines through computational methods and partnerships.
Work here?Claim your company
Industries
Company Size
501-1,000
Company Stage
IPO
Headquarters
New York City, New York
Founded
1990
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$951.4M
Above
Industry Average
Funded Over
11 Rounds
Schrödinger reported third quarter 2026 revenue of $64.49 million and a net loss of $37.71 million. The software and drug discovery company raised its full year 2026 annual contract value guidance to between $222 million and $232 million. It also updated its drug discovery revenue outlook to $75 million to $85 million. Operating expenses fell 13%, while more customers adopted its Bunsen platform. Partnered programs added support, including milestones from Structure Therapeutics and Takeda's filing for zasocitinib. Analysts expect earnings of $25.4 million on revenue of $356.2 million by 2029, implying 11.2% annual revenue growth. The company remains loss making and relies on milestone and collaboration income.
Schrodinger (NASDAQ:SDGR) price target raised to $21.00. Schrodinger (NASDAQ:SDGR - Free Report) had its price objective hoisted by UBS Group from $19.00 to $21.00 in a research note issued to investors on Tuesday morning, Marketbeat.com reports. UBS Group currently has a neutral rating on the stock. Several other equities analysts have also recently issued reports on the stock. Zacks Research upgraded shares of Schrodinger from a "hold" rating to a "strong-buy" rating in a research note on Monday, October 5th. KeyCorp lifted their price target on shares of Schrodinger from $20.00 to $32.00 and gave the stock an "overweight" rating in a research note on Friday, October 16th. TD Cowen lifted their price target on shares of Schrodinger from $20.00 to $31.00 and gave the stock a "buy" rating in a research note on Tuesday, October 13th. Weiss Ratings raised shares of Schrodinger from a "sell (e+)" rating to a "sell (d-)" rating in a report on Thursday, August 27th. Finally, Wall Street Zen upgraded shares of Schrodinger from a "strong sell" rating to a "hold" rating in a research report on Saturday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Schrodinger presently has an average rating of "Moderate Buy" and a consensus target price of $25.83. Schrodinger price performance. Shares of NASDAQ:SDGR opened at $22.60 on Tuesday. The company has a market cap of $1.67 billion, a P/E ratio of -30.54 and a beta of 1.62. Schrodinger has a 1 year low of $10.94 and a 1 year high of $33.78. The stock's fifty day moving average price is $23.94 and its 200-day moving average price is $17.81. Schrodinger (NASDAQ:SDGR - Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported $0.08 EPS for the quarter, beating the consensus estimate of ($0.41) by $0.49. Schrodinger had a negative return on equity of 16.37% and a negative net margin of 20.98%. The company had revenue of $58.89 million for the quarter, compared to analysts' expectations of $47.19 million. During the same period last year, the firm posted ($0.65) earnings per share. Schrodinger's revenue was up 7.5% compared to the same quarter last year. On average, sell-side analysts anticipate that Schrodinger will post -1.50 earnings per share for the current year. Insider activity at Schrodinger. In related news, insider Karen Akinsanya sold 31,599 shares of the company's stock in a transaction on Thursday, September 17th. The stock was sold at an average price of $29.37, for a total transaction of $928,062.63. Following the completion of the sale, the insider owned 69,956 shares in the company, valued at approximately $2,054,607.72. This represents a 31.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.10% of the stock is owned by insiders. Institutional inflows and outflows. Institutional investors and hedge funds have recently bought and sold shares of the company. GAMMA Investing LLC increased its position in shares of Schrodinger by 5.7% during the 3rd quarter. GAMMA Investing LLC now owns 14,353 shares of the company's stock valued at $446,000 after purchasing an additional 772 shares during the last quarter. Kestra Advisory Services LLC lifted its stake in shares of Schrodinger by 2.0% in the 1st quarter. Kestra Advisory Services LLC now owns 51,429 shares of the company's stock worth $584,000 after purchasing an additional 1,002 shares during the period. Root Financial Partners LLC bought a new position in shares of Schrodinger in the 3rd quarter worth approximately $50,000. Sterling Capital Management LLC boosted its holdings in shares of Schrodinger by 843.8% in the third quarter. Sterling Capital Management LLC now owns 1,916 shares of the company's stock worth $59,000 after buying an additional 1,713 shares during the last quarter. Finally, Entropy Technologies LP boosted its holdings in shares of Schrodinger by 17.9% in the first quarter. Entropy Technologies LP now owns 15,257 shares of the company's stock worth $173,000 after buying an additional 2,311 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors. Schrodinger company profile. Schrödinger, Inc develops computational software and services designed to support pharmaceutical, biotechnology and materials research. Its platform uses physics-based modeling, machine learning and other computational methods to help scientists analyze molecular interactions, design compounds and prioritize candidates for experimental testing. The company's software offerings include tools for molecular modeling, quantum chemistry, molecular dynamics, virtual screening, property prediction and free-energy calculations. Further reading. Receive News & Ratings for Schrodinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrodinger and related companies with MarketBeat.com's FREE daily email newsletter.
Schrodinger (NASDAQ:SDGR) insider Karen Akinsanya sells 31,599 shares. September 22, 2026 by InsiderTrades.com Key points. * Insider sale: Karen Akinsanya sold 31,599 Schrodinger shares for approximately $928,063 at an average price of $29.37, reducing her direct holdings by 31.12% to 69,956 shares. The transaction was made under a pre-arranged Rule 10b5-1 trading plan. * Operating results: Schrodinger reported quarterly revenue of $58.89 million, up 7.5% year over year, and adjusted earnings of $0.08 per share, exceeding the consensus estimate for a $0.41 loss. * Market outlook: Shares opened at $30.24 and have risen sharply within a $10.94-$31.03 12-month range, while analysts maintain a consensus "Hold" rating and an average price target of $20.50. Schrodinger, Inc. (NASDAQ:SDGR - Get Free Report) insider Karen Akinsanya sold 31,599 shares of the stock in a transaction on Thursday, September 17th. The shares were sold at an average price of $29.37, for a total transaction of $928,062.63. Following the completion of the sale, the insider directly owned 69,956 shares in the company, valued at approximately $2,054,607.72. This represents a 31.12% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Schrodinger trading up 4.2%. Schrodinger stock opened at $30.24 on Tuesday. Schrodinger, Inc. has a 12-month low of $10.94 and a 12-month high of $31.03. The firm has a 50-day moving average price of $18.79 and a 200-day moving average price of $15.33. The firm has a market capitalization of $2.23 billion, a PE ratio of -40.86 and a beta of 1.69. Schrodinger (NASDAQ:SDGR - Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.08 EPS for the quarter, beating the consensus estimate of ($0.41) by $0.49. Schrodinger had a negative net margin of 20.98% and a negative return on equity of 16.37%. The company had revenue of $58.89 million for the quarter, compared to the consensus estimate of $47.19 million. During the same period in the prior year, the firm posted ($0.65) EPS. The firm's revenue was up 7.5% compared to the same quarter last year. As a group, sell-side analysts predict that Schrodinger, Inc. will post -1.5 earnings per share for the current fiscal year. Hedge funds weigh in on Schrodinger. Discover more Insider trading reports NASDAQ company profiles Institutional investors have recently modified their holdings of the stock. EverSource Wealth Advisors LLC boosted its holdings in shares of Schrodinger by 722.8% in the fourth quarter. EverSource Wealth Advisors LLC now owns 1,374 shares of the company's stock valued at $25,000 after purchasing an additional 1,207 shares during the period. Hantz Financial Services Inc. increased its holdings in Schrodinger by 5,025.8% during the 4th quarter. Hantz Financial Services Inc. now owns 1,589 shares of the company's stock worth $28,000 after purchasing an additional 1,558 shares during the period. Fideuram Intesa Sanpaolo Private Banking S.P.A. bought a new stake in Schrodinger during the 4th quarter valued at $36,000. Purpose Unlimited Inc. bought a new stake in Schrodinger during the 4th quarter valued at $47,000. Finally, Allworth Financial LP purchased a new stake in shares of Schrodinger in the 2nd quarter worth $86,000. 79.05% of the stock is owned by hedge funds and other institutional investors. Analyst upgrades and downgrades. Several brokerages have recently weighed in on SDGR. UBS Group began coverage on Schrodinger in a report on Friday, August 14th. They issued a "neutral" rating and a $19.00 price target on the stock. Weiss Ratings raised Schrodinger from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Thursday, August 27th. Finally, Wall Street Zen upgraded Schrodinger from a "strong sell" rating to a "hold" rating in a research note on Saturday, August 8th. Three analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $20.50. About Schrodinger. Schrödinger, Inc develops computational software designed to accelerate drug discovery and materials science research. Its platform uses physics-based modeling, machine learning and related computational methods to help scientists analyze molecular structures, predict interactions and identify potential compounds for further development. The company's software products support a range of research activities, including molecular modeling, virtual screening, structure-based drug design, free-energy calculations and collaborative data management. This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected]. Insider Buying or Selling at Schrodinger? Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Schrodinger and related companies. From Our Partners
Ajax Therapeutics, Inc., a biopharmaceutical company developing next generation JAK inhibitors for patients with myeloproliferative neoplasms (MPNs), today a...
Schrödinger 2026-3 release advances composite matrix design tools. The update adds coarse-grained backmapping for resin structure modeling and an agentic AI co-scientist, Bunsen, now in beta. Senior Managing Editor, CompositesWorld and Products Finishing Source | Schrödinger Schrödinger (New York, N.Y., U.S.) has released the 2026-3 version of its Materials Science Suite, adding capabilities the company says advance the digital design of composite matrix formulations alongside a new agentic AI tool, machine learning model refinements and expanded structure prediction tools. The release is available for download to Schrödinger users. A central addition is coarse-grained backmapping, which maps coarse-grained structures to all-atom molecular models. According to Schrödinger, this enables development of structural models for complex resin mixtures, supporting property assessment across length scales relevant to composite matrix formulation. Learn to cut the cost and time of tooling. CW's editors are tracking the latest trends and developments in tooling, from the basics to new developments. This collection, presented by Composites One, features recent CW stories that detail a range of tooling technologies, processes and materials. Download Collection The release also updates MS Reactivity workflows, aimed at exploring degradation behavior in polymer systems. The Nanoreactor tool within that workflow now includes a simplified interface with dedicated tabs for workflow and sampling settings, along with a scaled setup for biasing potential, changes that provide more robust tools for assessing thermal and other degradation risks. Along with the release, Schrödinger also officially introduced Bunsen, a chemistry-native agentic co-scientist now available to early access customers. The tool is designed to execute complex workflows, submit and monitor jobs, and self-correct in real time. Additional enhancements in the release include a custom extension of Schrödinger's foundational machine learning force field, which allows users to refine MPNICE force field parameters using custom structure-energy data for specific chemical spaces, and enhanced featurization for solid-state machine learning, which builds machine learning models based on MPNICE embeddings. The release additionally includes extended crystal structure prediction capability, capable of predicting crystal structures for salts, hydrates, solvates and cocrystals. * Testing to support composite bolted joint analysis An overview of ASTM Standard Guide D8509, and its coupon-level mechanical testing of design properties for analyzing composite bolted joints. * Cutting 100 pounds, certification time for the X-59 nose cone Swift Engineering used HyperX software to remove 100 pounds from 38-foot graphite/epoxy cored nose cone for X-59 supersonic aircraft. * Troubleshooting thermoplastic composite stamp forming Understand the basic science of TPC stamp forming, a manufacturing process steadily gaining momentum in aerospace and mobility applications thanks to its rapid forming, short cycle times and automated methods.
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
501-1,000
Company Stage
IPO
Headquarters
New York City, New York
Founded
1990
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs